News
Search EMA's news announcements
Leqembi (lecanemab) recommended for treatment of early Alzheimer’s disease
Regulatory update
Re-examination concludes that benefits outweigh risks in a restricted patient population
Platform technologies enable rapid response to emerging infectious disease threats
Outcomes of the Committee for Veterinary Medicinal Products (CVMP) meeting.
PRAC carried out its broad range of responsibilities for managing the risks associated with medicine use
The European Medicines Agency's (EMA) office is closed on Friday 1 November 2024 for All Saints’ Day.
Global regulators discuss available knowledge supporting mpox medicine development and approval
Re-examination concludes effectiveness has not been confirmed
Ten new medicines recommended for approval; another six medicines recommended for extension of their therapeutic indications